Skip to main content

Safety of i.v. administration of redback spider antivenom

Buy Article:

$48.00 plus tax (Refund Policy)

Abstract:

Abstract

It is unclear what the risk of allergic reactions is with appropriately given dilute i.v. redback spider antivenom (RBSAV). Ninety-five i.v. administrations of RBSAV referred from January 2001 to November 2006 were reviewed. All patients had local pain, 72% radiating pain, 57% diaphoresis and 39% systemic effects. Four patients (4%) had immediate systemic hypersensitivity reactions: none were severe, one was moderate and three mild. In 32 patients followed up for 2 weeks, three (10%) developed serum sickness. RBSAV given i.v. had a low reaction rate.

Keywords: adverse reaction; allergy; antivenom; envenoming; latrodectism; redback spider

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1445-5994.2007.01513.x

Publication date: December 1, 2007

bsc/imj/2007/00000037/00000012/art00007
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more